Delivra Health BrandsTSXV:DHB EBITDA Margin % is -76.98% as of Mar. 2026. The stock has 3 warning signs investors should review. Among 953 Drug Manufacturers companies, Delivra Health Brands ranks worse than 79.54% on this metric.
Delivra Health Brands (TSXV:DHB) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Delivra Health Brands EBITDA Margin % Related Terms
Delivra Health Brands EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Delivra Health Brands's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Delivra Health Brands's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Delivra Health Brands EBITDA Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Delivra Health Brands's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Delivra Health Brands's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Delivra Health Brands (TSXV:DHB) has a EBITDA Margin % of -76.98% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Delivra Health Brands and its competitors. According to the industry distribution chart, Delivra Health Brands ranks #758 out of 953 companies in the Drug Manufacturers industry, placing it in the top 79.5%.
Is Delivra Health Brands' EBITDA Margin % too high?
Delivra Health Brands' current EBITDA Margin % is -76.98%. Based on the distribution chart, Delivra Health Brands ranks #758 out of 953 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Delivra Health Brands' EBITDA Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Delivra Health Brands ranks #758 out of 953 companies for EBITDA Margin %. This places Delivra Health Brands in the lower half of its industry. The industry median EBITDA Margin % is 12.54. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 12.54, based on 953 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Delivra Health Brands and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Delivra Health Brands's current EBITDA Margin % is -76.98%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Delivra Health Brands stock overvalued right now?
Based on GuruFocus' analysis, Delivra Health Brands (TSXV:DHB) is currently considered Possible Value Trap. The stock's GF Value™ is C$0.25, compared to a current price of C$0.10 — trading 60% below its estimated fair value. The current EBITDA Margin % is -76.98%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Delivra Health Brands (TSXV:DHB), the current EBITDA Margin % is -76.98% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Delivra Health Brands Inc helping people take control of health with alternative wellness solutions. Its portfolio features brands like Dream Water and LivRelief that deliver relief from common, everyday issues like chronic pain, anxiety, and sleeplessness. The principal activities of the company are to provide lifestyle and health and wellness products to consumers and patients in regulated markets. The company geographically operates in Canada and United States, out of which it generates maximum revenue from Unites States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:DHB has been successfully added to your 